PharmaShots | Incisive News in 3 Shots

Subscribe Now

Early-Stage EGFR-Mutated Lung Cancer

AstraZeneca's Tagrisso (osimertinib) Receives EU's CHMP Positive Opinion for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer

AstraZeneca's Tagrisso (osimertinib) Receives EU's CHMP Positive Opinion for the Adjuvant Treatment of Patients with Early-Stage E...

April 26, 2021

AstraZeneca's Tagrisso (osimertinib) Receives the NMPA's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer

AstraZeneca's Tagrisso (osimertinib) Receives the NMPA's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mut...

April 14, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us